Research & Development



  “呃,我......”王淼淼語塞,撓撓腦袋,“幫你們加油助威啊。”   “同...同居了?”久久视频这里只精品   陸昔年︰[不不不]那什麼,有趣開心什麼的是王淼淼說的,他經常在寢室念叨會長,我也就不小心記下了。思思热99re热在线视频   386L︰關鍵是還去這麼早佔座,而我男朋友現在還睡得跟豬一樣!!![流下悔恨的淚]   “好。”人人超碰xxoo免费视频   “感覺今天Lin神心情好好, 可以加播一小時嗎?”

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo